co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
While Oak Tree Road has more than a dozen jewelry stores, mostly owned by Indian Americans, Menendez said the arrival of Tanishq at this popular Indian shopping destination is significant and different from others.
"The company has received final approval from the US Food and Drug Administration (USFDA) to market tizanidine hydrochloride capsules, USP in strengths of 2mg, 4mg and 6mg," Zydus Cadila said in a regulatory filing today.
Drug firm Lupin has launched in the American market its Clobetasol Propionate topical solution used for providing relief in various skin conditions of the scalp.
Drug firm Zydus Cadila today said it has received approval from the US health regulator to market methotrexate tablets, a chemotherapy drug, in the American market.
The company has received "final approval of abbreviated new drug application (ANDA) from the US Food and Drug Administration (USFDA) for generic version of Budesonide capsules (enteric coated), 3 mg," Natco Pharma said in a filing to BSE.
The company "has received final approval for abbreviated new drug application (ANDA) containing a paragraph IV certification filed with the United States Food and Drug Administration (USFDA) for generic versions of Tamiflu oral capsules...", Natco Pharma said in a filing to BSE.
The USFDA had earlier given approval to market a generic version of Janssen Pharmaceuticals, Inc.'s Ortho Tri-Cyclen tablets in the same strengths, it added.
"The company's US based 100 per cent subsidiary company Zydus Pharmaceuticals (USA) Inc (Zydus) will begin informing on July 12, 2016 its customers that Zydus will start selling an authorized generic of Asacol HD (mesalamine delayed - release tablets 800 mg) in the US commencing on August 1, 2016," Cadila Helathcare said in a filing to the BSE.
The company "has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Bupivacaine Hydrochloride Injection USP, 0.25 percent (2.5 mg/mL) and 0.5 percent (5 mg/mL) 50 mL multiple dose vials," Aurobindo Pharma said in a filing to BSE.
"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Lacosamide tablets, 50 mg, 100 mg, 150 mg and 200 mg," Aurobindo Pharma said in a filing on BSE.
"Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market carboplatin injection, 10mg/ml in 5ml, 15ml and 45ml," Cadila Healthcare said in a BSE filing.
"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Rivastigmine Tartrate Capsules USP, 1.5 mg, 3 mg, 4.5 mg and 6 mg," Aurobindo Pharma said in a BSE filing.
"Glenmark Pharmaceuticals Inc has been granted final approval by the US Food and Drug Administration (US FDA) for Frovatriptan Succinate Tablets, 2.5 mg," the company said in a BSE filing today.
"Glenmark Pharmaceuticals Inc has been granted final approval by the US Food and Drug Administration (US FDA) for Potassium Chloride extended release capsules USP, 10mEq, of Actavis Laboratories FL, Inc," the company said in a BSE filing.
The company has received received the final approval from the United States Food and Drug Administration (FDA) to market Fyavolv tablets, Lupin today said in a statement. "Lupin's US subsidiary, Lupin Pharmaceuticals Inc shall commence promoting the product in the US shortly," it added.
Ajanta Pharma USA Inc, a subsidiary of the company today announced the launch of Montelukast Sodium immediate release tablets in the strength of 10mg and Montelukast Sodium chewable tablets in 4mg & 5mg strengths, Ajanta Pharma said in a filing to BSE.
Ramesh Chandak, Managing Director, KEC International said the company aims to target the American market to maintain growth and order book portfolio.
Drug firm Dr Reddy's Laboratories today said it has launched it's generic Finasteride tablets used for treating male pattern hair loss in the American market.
Aurobindo Pharma today said it has received approval from the US health regulator to make and market Modafinil tablets - used for treating excessive sleepiness disorder in adults - in the American market.
Glenmark Pharmaceuticals on Monday said its US subsidiary Glenmark Generics Inc has received US health regulator's approval to market its generic oral contraceptives Norgestimate and Ethinyl Estradiol tablets in the American market.
Drug firm Dr Reddy's Laboratories today said it has launched levocetirizine tablets, which are used for relieving allergies, in the American market.
